Hearing Loss, Sudden: Clinical Trials

9 trials for Hearing Loss, Sudden, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 9 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 5, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 26Completed 3, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Hearing Loss, Sudden: new trials by email Literature Review of Hearing Loss, Sudden trials Research Report on Hearing Loss, Sudden

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden
Phase 1 / Phase 2WithdrawnSeoul National University Hospital2026-12-152026-05-22
Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
Tympanic injection of hUC-MSC-sEV-003 (small extracellular vesicles) at low doses, Tympanic injection of hUC-MSC-sEV-003 (small extracellular vesicles) at moderate doses, Tympanic injection of hUC-MSC-sEV-003 (small extracellular vesicles) at high doses - Sudden Hearing Loss, Extracellular Vesicles
Phase 1 / Phase 2Not yet recruitingThe Affiliated Hospital of Qingdao University92026-02-282026-03-25
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
NS101, Placebo - Seneorineural Deafness, Sudden Sensorineural Hearing Loss
Phase 1 / Phase 2CompletedNeuracle Science Co., LTD.1132024-02-152026-11-02
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
Dexamethasone, Hyaluronic acid - Hearing Loss, Sudden, Hearing Loss, Ototoxic
Phase 1 / Phase 2CompletedSeoul National University Hospital152021-07-222024-10-24
Phase I Clinical Study of HY01 in Patients
HY01 - Sudden Sensorineural Hearing Loss
Phase 1UnknownHeyu (Suzhou) Pharmaceutical Technology Co., Ltd122021-06-232021-07-14
FX-322 in Adults With Severe Sensorineural Hearing Loss
FX-322, Placebo - Hearing Loss, Sensorineural, Noise Induced Hearing Loss
Phase 1CompletedFrequency Therapeutics312020-11-022022-02-01
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
FX-322, placebo - Presbycusis, Hearing Loss, Sensorineural
Phase 1CompletedFrequency Therapeutics302020-09-172022-05-25
Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
anakinra - Hearing Loss, Sudden
Phase 1 / Phase 2TerminatedAndrea Vambutas22013-10-012017-03-13
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
Anakinra - Sensorineural Hearing Loss, Autoimmune Inner Ear Disease
Phase 1 / Phase 2CompletedAndrea Vambutas132011-06-012018-01-10

Narrower conditions

Hearing Loss, Sensorineural (5)  ·  Hearing Loss, Noise-Induced (3)  ·  Meniere Disease (2)  ·  Hearing Loss (1)  ·  Hearing Loss, Hidden (1)  ·  Presbycusis (1)

Broader conditions

Ear Diseases (9)  ·  Hearing Disorders (9)  ·  Nervous System Diseases (9)  ·  Neurologic Manifestations (9)  ·  Otorhinolaryngologic Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Sensation Disorders (9)  ·  Signs and Symptoms (9)  ·  Hearing Loss (8)  ·  Endolymphatic Hydrops (2)  ·  Labyrinth Diseases (2)  ·  Hearing Loss, Sensorineural (1)

Interventions

Dexamethasone (2)  ·  Hyaluronic Acid (2)  ·  Interleukin 1 Receptor Antagonist Protein (2)  ·  Indocyanine Green (1)

Sponsors

Andrea Vambutas (2)  ·  Frequency Therapeutics (2)  ·  Seoul National University Hospital (2)  ·  Heyu (Suzhou) Pharmaceutical Technology Co., Ltd (1)  ·  Neuracle Science Co., LTD. (1)  ·  The Affiliated Hospital of Qingdao University (1)

Countries

United States (4)  ·  China (2)  ·  South Korea (2)

Top investigators

Andrea Vambutas, MD (2)  ·  Carl LeBel, PhD (2)  ·  Dong Pin, Doctor (1)  ·  Joseph Park, M.D. (1)

Results publications

PMID 25133431

NIH funding

R33DC011827 (1)